Sandoz

0SAN.L | LSE | 0 Followers
CHF 40.20 +1.14% CHF 0.45
Follow
Loading...

Profile

Sandoz Group AG is a Swiss pharmaceutical company that is part of the Novartis group and specializes in the production of generic drugs and biosimilar products. Founded in 1886, it is now one of the global leaders in generic medicine. Sandoz focuses on providing high-quality and affordable treatment for the general public, particularly in areas such as oncology, cardiovascular diseases, infections, and neurology. The company is known for its ability to innovate in biotechnology and produce drugs that are identical to the originals but more affordable.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade